Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
22.0%
% of GNOM's 41 holdings also in FBT
30.0%
% of FBT's 31 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GNOM |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
MODERNA, INC. | 4.5% | 3.3% | 3.3% |
|
BIOMARIN PHARMACEUTICAL INC | 3.7% | 3.3% | 3.3% |
|
ILLUMINA INC | 3.5% | 3.2% | 3.2% |
 |
BIONTECH SE SPONSORED ADR | 3.1% | 3.5% | 3.1% |
|
NATERA INC | 7.3% | 3.1% | 3.1% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to FBT
 |
ENI SPA-SPONSORED ADR | 7.7% |
|
CRISPR THERAPEUTICS AG | 4.8% |
|
ULTRAGENYX PHARMACEUTICAL IN | 4.4% |
|
AGILENT TECHNOLOGIES INC | 4.4% |
|
NATERA INC | 4.2% |
|
SAREPTA THERAPEUTICS INC | 3.7% |
|
QIAGEN NV | 3.6% |
|
BIO-TECHNE CORPORATION | 3.5% |
|
ROCKET PHARMACEUTICALS, INC. | 3.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 3.2% |
GNOM Underweight Relative to FBT
|
INTRA-CELLULAR THERAPIES INC | -3.8% |
|
UNITED THERAPEUTICS CORP | -3.5% |
|
AMGEN INC | -3.5% |
|
HALOZYME THERAPEUTICS INC | -3.4% |
|
CATALYST PHARMACEUTICAL PART | -3.4% |
|
REGENERON PHARMACEUTICALS | -3.4% |
|
EXELIXIS INC | -3.4% |
|
ACADIA PHARMACEUTICALS INC | -3.4% |
|
BIOGEN IDEC INC | -3.4% |
 |
GENMAB A/S SPONSORED ADR | -3.4% |